Loading provider…
Loading provider…
Nephrology Physician in Roseville, CA
NPI: 1124265822Primary Practice Location
KAISER FOUNDATION HOSPITAL - ROSEVILLE
1600 Eureka Rd, Roseville, CA
Primary Employer
SUMMIT NEPHROLOGY MEDICAL GROUP, INC.
HQ Phone
Get M.D Sourabh's Phone NumberMobile
Get M.D Sourabh's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2009 - 2027
NY State Medical License
2024 - 2026

American Board of Internal Medicine
Nephrology
Zucker School of Medicine at Hofstra/Northwell
Residency • Internal Medicine
2006 - 2009
B.J. Medical College - University of Pune
Medical School
Until 2002
UCSF School of Medicine
medschool.ucsf.edu
Fellowship • Nephrology
2009 - 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 206 | 333 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 88 | 88 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 65 | 107 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 26 | 34 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 17 | 18 |
Pharmacological inhibition of S-nitrosoglutathione reductase improves endothelial vasodilatory function in rats in vivo.
Authors: Gary Rosenthal
Publication Date: 2013-01-26
Authors: Kharait, Sourabh, Haddad, Daniel J, Springer, Matthew L
Journal: Biochem Biophys Res Commun
Publication Date: 2011-05-20
Authors: Mamoune, Asmaa, Kassis, Jareer, Kharait, Sourabh, Kloeker, Susanne, Manos, Elisabeth, Jones, David A, Wells, Alan
Journal: Exp Cell Res
Lead Sponsor: Christopher Granger, MD
Collaborators: Bristol-Myers Squibb
Intervention / Treatment: DRUG: warfarin, DRUG: apixaban